SCROLL NEWS / DISCOVERY
Search headlines
Find the stories shaping the conversation.
Results for " analyst " 1,204 found 🔀 AI-powered Shuffle
Dale Jr. Fires Back At Criticism Of NASCAR Broadcast
Dale Earnhardt Jr. has been involved in the NASCAR media space for a while now, so the legendary driver is used to criticism. Over the weekend, some NASCAR fans expressed frustration with the TNT broadcast, as some believed that the analysts were underestimating the chances of Shane van Gisbergen ...
Carnell Tate's impressive performance during Titans' OTAs draws praise
Tennessee Titans rookie Carnell Tate is turning heads at OTAs after the team surprised analysts with his high draft selection.
CNN Host and Chief Legal Analyst Laura Coates, breaks down the major rulings by the Supreme Court on presidential power.
ESPN Analyst Chiney Ogwumike Defends Alyssa Thomas' Behavior
ESPN WNBA analyst Chiney Ogwumike is coming to the defense of Phoenix Mercury forward Alyssa Thomas. Thomas was suspended for one game and fined for her hits on Indiana Fever guard Caitlin Clark last week. Thomas was caught hitting Clark in the groin and the neck, though she wasn't called for a ...
Peptides are the latest US health craze. But what exactly are they?
While peptides are taking the health and wellness category by storm for various use cases, what exactly are they? Leerink Partners senior research analyst Michael Cherny helps break down what a peptides are, how people are choosing them for personal health and recovery reasons, and who the biggest winners in consumer pharmaceuticals could be if their popularity continues to grow.
New and updated geographic boundaries in ArcGIS Business Analyst (June 2026)
With the June 2026 data release, there are new U.S. geographic boundaries in ArcGIS Business Analyst, including neighborhoods, ZCTAs, and CSAs.
College Football Analyst Calls Historic Program No Longer 'Relevant'
College football analyst Paul Finebaum didn't hold back on his thoughts on the University of Michigan and its football program. Michigan won the national championship for the 2023 season, but after the win, Jim Harbaugh went to the NFL, and the program was accused of stealing signs. The program ...
About 3 million people have dropped Obamacare health coverage after subsidies expire and costs rise
The Department of Health and Human Services suggests the 13% drop is due to a federal crackdown on fraudulent enrollmentut, but health analysts believe it's more likely related to the Jan. 1 expiration of federal subsidies.
Dave & Buster's Entertainment (NASDAQ:PLAY) Earns Market Perform Rating from Analysts at Citizens Jmp
Citizens Jmp began coverage on Dave & Buster's Entertainment in a report on Monday. They set a "market perform" rating for the company.
Millions drop Obamacare health coverage after subsidies expire and costs rise
Health analysts say the drop in enrollment was likely related to the Jan. 1 expiration of federal subsidies, which caused a surge in plan costs that resulted in many people being unable to pay their premiums.
After budget impasse, business as usual for Virginia Democrats, analysts say
This has been a budget battle like none other, with big personalities, personal attacks and what looked like a high-stakes game of chicken with days to go before the Virginia state government couldn’t pay its bills.
If USMCA is not renewed, analysts expect uncertainty for businesses
US President Donald Trump has warned he would 'rather not have' the free trade agreement ahead of its July 1 review.
Jimmie Johnson joins TNT Sports as NASCAR analyst in 2026
Jimmie Johnson is joining TNT Sports as a NASCAR analyst in select races during the 2026 Cup Series season.
Bernstein Says Life Science Sector is Improving, Resumes Thermo Fisher Scientific (TMO) Coverage
Thermo Fisher Scientific Inc. (NYSE:TMO) is included among Billionaire Steven Cohen’s Top 11 Dividend Stock Picks. On June 26, Bernstein resumed coverage of Thermo Fisher Scientific Inc. (NYSE:TMO) with a Market Perform rating. It also set a $520 price target after the analyst returned from maternity leave. In a research note, the firm said “Many […]
Morgan Stanley Raises PT on International Business Machines (IBM) Stock
International Business Machines Corporation (NYSE:IBM) is one of the Best Cloud Computing Stocks to Buy According to Hedge Funds. On June 23, Morgan Stanley lifted its price objective on the company’s stock to $267 from $225, and maintained an “Equal Weight” rating on the shares. As per the analyst, Dell and HPE earnings demonstrate that the enterprise server demand […]
Starz Entertainment (STRZ) Stock Sees Fair Value Lift After Q1 Analyst Target Increases
Price targets for Starz Entertainment have shifted as the analyst fair value estimate moved from US$19.38 to US$28.50, putting a higher reference point in focus for investors tracking the stock. Recent Street research has turned more constructive after the Q1 report, with several firms lifting price targets and updating models to reflect how they now view execution risks and valuation support. In the sections that follow, you will see how to interpret these changing targets and what they...
Colby Parkinson is extremely valuable to the Rams offense
Analysts around the league are clamoring for him, but they’re almost certainly not going to pry him away from L.A.
Presidential ambitions? Moore speech to contrast Trump rally
Wes Moore has repeatedly said he's focused on his role as governor, but political analysts say his actions point to a run for higher office.
2027 iPhone 18 and iPhone 18e to Get 9GB RAM and A20 Chip
The lower-end iPhone 18 models set to launch in spring 2027 will feature 9GB DRAM, up from 8GB, according to Apple analyst Ming-Chi Kuo. Kuo says the A20 chip Apple plans to use for the devices will have 1.5GB x 6 dies for a total of 9GB RAM, instead of 2GB x 4 dies as the current lower-end iPhone 17 models use. By lower-end iPhones, Kuo is likely referencing the iPhone 18 and the iPhone 18e, both of which are rumored to be coming around March or April of 2027.
PepsiCo Q2 earnings expected to reflect weakness in North American snack business, delayed recovery
PepsiCo Inc (NASDAQ:PEP, XETRA:PEP) earnings outlook was trimmed by Bank of America analysts ahead of the company’s second quarter results, with softer-than-expected performance in its North American snacks business offsetting steadier international trends. The analysts lowered their fiscal...
Trump likely to ‘lose’ on birthright citizenship case, political analyst says
Fox News senior political analyst Juan Williams discusses the Supreme Court set to issue a ruling on birthright citizenship on ‘Special Report.’
Moore links Maryland primary to Mamdani-backed wins; analysts disagree
Gov. Wes Moore says Maryland’s primary election showed voters rejected the status quo, but political analysts say the results reflect a more complicated picture.
Grand Theft Auto VI pre-orders open, but don’t expect a physical copy
The blockbuster launch is expected to dwarf the box office takings of the year’s biggest movies with one industry analyst predicting it could make $1bn within an hour
Hims' obesity drug business may get boost as employers drop coverage
Telehealth provider Hims and Hers Health may get a boost next year from employers dropping coverage of weight-loss drugs like Novo Nordisk's Wegovy and Eli Lilly's Zepbound and Foundayo to rein in costs, investors and analysts say.
Is This How Nike Is Shaking Up Its China Business?
BNP analyst Laurent Vasilescu considers the risk for Nike if a media report is accurate about a plan to change in distribution in China.
Health insurers propose high rate hikes for 2027 Minnesota plans
To find out why and how much it'll burden customers, policy analyst Matt McGough with KFF Health News joined Morning Edition Wednesday.
This health data provider could benefit as AI reshapes drug research
Harvey Stober, senior equity analyst and correspondent at CNBC, explains why this healthcare company could benefit from artificial intelligence reshaping the drug industry thanks to its treasure trove of data.
Why 2 pitches from Seattle Mariners starters jump out
Logan Gilbert is riding one pitch to success, while Emerson Hancock is struggling with one of his own, Seattle Mariners analyst Ryan Rowland-Smith explains.
CBS Sports ranks Falcons' 2026 offseason among worst in NFL
CBS Sports analyst ranks Falcons 2026 offseason fifth-worst in the NFL
Dave And Buster's Entertainment (PLAY) Stock Sees Fair Value Cut After Q1 Analyst Revisions
The fair value estimate for Dave & Buster's Entertainment has been revised from US$18.88 to US$17.00, bringing the price target closer to updated assumptions on comparable sales and earnings. Analysts link this adjustment to a balance of cautious near term expectations after Q1 and ongoing optimism that longer term changes in the business could still support the story if execution improves. Read on to see how this evolving narrative might shape how you track Dave & Buster's Entertainment from...
Analyst breaks down road map for Titans' preseason joint practices
The Tennessee Titans have scheduled three joint practices to prepare for the 2026 season under new leadership.
Oklahoma ACA insurer Mending to end health plans after this year
A health policy analyst says the move comes amid a broader trend of insurer exits as several federal policy changes fuel declining enrollment.
Alexi Lalas scolded by former USA teammate over ‘unwatchable’ Fox Sports punditry at World Cup
The Fox Sports pundit has attracted criticism for his views, while the chemistry with fellow analysts Thierry Henry, and Zlatan Ibrahimovic has left some viewers uncomfortable
BMO Lowers Expectations After Dave & Buster’s Entertainment, Inc. (PLAY)’s EBITDA Miss
Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) is among the best low priced stocks to get rich in 2026. Andrew Strelzik, an analyst at BMO Capital, trimmed the price target on Dave & Buster’s Entertainment, Inc. (NASDAQ:PLAY) to $22 from $24 on June 16. As highlighted by the analyst, the company’s Q1 EBITDA missed consensus by […]
"This is going to be a niche device" – Analysts react to the $1,000+ Steam Machine price reveal
Mat Piscatella, Joost van Dreunen, Manu Rosier, and Piers Harding-Rolls offer their thoughts on the price implications for Project Helix and PS6
Goldman Sachs analysts say EV adoption set to hammer demand for oil
Goldman Sachs says a shift spurred by the Iran War and its disruption to energy markets will put downward pressure on crude prices through 2027.
Brexit Has Cost the UK Growth, Analysts Say, in the Decade Since the Vote
Citing lower trade and investment, analysts broadly agree that Britain’s economy is smaller than it would have been if the country had stayed in the E.U.
Indian shares set to pause after oil-led rally
Indian shares were set to open flat on Tuesday, with analysts expecting a phase of consolidation in the absence of fresh triggers after gains in six out of seven sessions, while sentiment remained constructive on easing Middle East tensions.
Monday, June 22, 2026: The Club says this legacy tech stock's foundry business presents a major opportunity
Go behind the scenes with Jim Cramer and Jeff Marks of the CNBC Investing Club as they talk candidly about the market's biggest headlines, analyst calls and holdings in the Charitable Trust—and see up close how they decide when, and if, to take action on stocks.
Apple's first Ultras are coming: 20 new products in 2026–2027 according to Bloomberg
Apple's new CEO John Ternus will begin his tenure in September with a wave of new products that will bring Apple fans many exciting new releases. Well-known Bloomberg analyst Mark Gurman has listed the most important new products coming our way after the summer break, including the first ones potentially bearing the “Ultra” moniker.
The Bucs unleashing Rueben Bain Jr. would help their defense
One analyst believes Tampa Bay's defense could benefit from allowing Rueben Bain Jr. to immediately play to his strengths.
The media has declared open season on Alexi Lalas
In the ever-growing genre of media criticism, few have ever been as soft a target as Fox Sports soccer analyst Alexi Lalas. It has seemingly become a once-every-four-years tradition. Fox will begin its World Cup coverage. Americans will rediscover everything they despise about the professional shit-stirrer. And a deluge of thinkpieces will follow, ripping the…
Wedbush Initiates Coverage on Flutter Entertainment (FLUT) Stock with Outperform Rating
Flutter Entertainment plc (NYSE:FLUT) is one of the Stocks with Potential to Explode in 2026. On June 17, Wedbush initiated coverage on the company’s stock with an “Outperform” rating and a price objective of $138.00. As per the analyst, the company is the world’s largest online sports betting and internet gaming operator and has exposure to the […]
Analyst Says Jaguars Should Extend Washington Before Season Starts
With Parker Washington poised for a massive breakout, Jacksonville must secure the rising star now before his market value skyrockets beyond the projected $20 million annual payday.
New research casts doubt on cannabis benefits, cites mental health risks
Fox News senior medical analyst Dr. Marc Siegel discusses new research on modern marijuana’s high THC potency and increased mental health risks on ‘Fox & Friends Weekend.’
CBS Sports will need a new NFL booth
CBS Sports is heading into the 2026 NFL season with presumably two open slots in its fourth broadcast booth. ESPN re-signed Jason McCourty to a new multi-year exclusive deal on Thursday, pulling him away from the CBS booth he shared last season with play-by-play man Andrew Catalon, analyst Charles Davis, and sideline reporter A.J. Ross.…
Roundup: Oil shock / AI receptionists / Warsh’s style
‘Baked-in’ damage: Even though the Strait of Hormuz has reopened in principle, analysts say the economic damage from the earlier disruption is already largely “baked in,” since supply chains, inventories and energy markets have already adjusted to shortages and higher costs. Oil prices have eased from their peak, but inflation pressures are expected to persist […]
Kendrick Perkins: These are the 3 best leaders I played with in the NBA
Kendrick Perkins played 14 years in the NBA. He is now an NBA analyst for ESPN.
Indian entertainment is structurally shifting: Anand Rathi
Omar Hinduja, Senior Analyst of Media and Entertainment at Anand Rathi, explains how India's entertainment landscape is rapidly developing - expanding its reach globally as it shifts to non-traditional media.
Analysts who cover MSG sports are bullish on the proposed breakup, says Jim Cramer
'Mad Money' host Jim Cramer talks if live sports entertainment play MSG is worthadding to your portfolio after the Knicks' big win.
Snap's $2,195 AR glasses may have cost an insane amount to develop, analyst estimates
Snap stock has had a down week following the hyped reveal of its latest AR glasses.
Analyst Perspectives on Oracle’s Strategy to Help Customers Secure Business Data against AI Threats
Oracle today announced its AI security strategy based on three principles: secure at source, secure at speed, and secure through resilience. To help customers accelerate and strengthen their security posture Oracle is making several of its most widely deployed and battle-tested database security, patching, testing, and lifecycle management tools available at no cost for a limited time, or at a 90% discount on one-year term licenses. This move has been positively received by leading industry analysts and reaffirms Oracle’s leadership in equipping enterprises to maximize their resilience in the face of increasing AI-era security threats.
Analyst predicts 49ers star to break long-standing NFL record
Christian McCaffrey has been in the NFL long enough where he is now staring at some NFL records.
Leidos (LDOS) Faces DHA Move To Replace It On Military Health Records
Defense Health Agency plans to replace Leidos Holdings (NYSE:LDOS) as lead systems integrator for the Military Health System electronic health record program. Change affects the company’s role in the multi year MHS GENESIS rollout across U.S. military treatment facilities. Decision introduces uncertainty for Leidos’ health segment and its position in the federal health IT market. Analysts have issued downgrades citing concerns about profit margins and organic growth alongside this contract...
Jimmie Johnson joining TNT Sports as analyst
As it enters the second season of its media rights deal, TNT Sports is bolstering its NASCAR coverage by adding Jimmie Johnson.
Jay Bilas recalls NFL tryout offer after college basketball career
During his interview with @EdEastonJr, ESPN Analyst Jay Bilas recalled his NFL tryout offer after concluding his college basketball career
Intel takes a major step toward turning around a business that’s bleeding cash
Intel’s new manufacturing process has entered a stage that signals the company is confident in its ability to bring on external customers, analysts say.
Analyst says Xbox CEO Asha Sharma’s Next 100 Days will be about “the job she was Actually Hired to do,” with Mass Layoffs Looming
Xbox chief executive officer Asha Sharma went from being the new face of Team Green, leading the platform into a new era, to being no different from the last in the eyes of players in the blink of an eye. After making Game Pass cheaper, re-centering console hardware and bringing exclusives back, Xbox fans praised her quick action and transparency. Now, however, with multiple studios reportedly being closed and more mass layoffs looming, she and her regime are no different from Spencer's. Industry veteran and analyst Joost van Dreunen calls it "the job she was actually hired to do." Van […]
Dave & Buster's Entertainment, Inc. Stock 12‑Month Price Target Cut to $19.78, Implies 61% Upside
Explore more price target data and ratings for Dave & Buster's Entertainment, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Dave & Buster's Entertainment, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet R…
Here Are Tuesday’s Best Wall Street Analyst Research Calls: Dynatrace, Emerson Electric, Exxon Mobil, Flutter Entertainment, Genuine Parts, nVent Electric, Palantir Technologies, Roku, and More
Pre-Market Stock Futures: Futures are trading modestly higher after a stunning opening to the week, as all major indices rocketed higher. The announcement of a cease-fire deal with Iran, which the leaders in that country acknowledged, called for reopening the Strait of Hormuz toll-free. While details will still be worked out over the next ... Here Are Tuesday’s Best Wall Street Analyst Research Calls: Dynatrace, Emerson Electric, Exxon Mobil, Flutter Entertainment, Genuine Parts, nVent Electric, Palantir Technologies, Roku, and More
Dave & Buster's Entertainment, Inc. Stock 12‑Month Price Target Cut to $20.11, Implies 63% Upside
Explore more price target data and ratings for Dave & Buster's Entertainment, Inc. on the Forecasts tab, and track all previous and future analyst recommendations for Dave & Buster's Entertainment, Inc. in the dedicated News Flow.Select reference data provided by FactSet. Copyright © 2026 FactSet R…
Shane Bowen a welcome addition to Patriots coaching staff
Bowen was hired as a defensive analyst in April.
Here Are Monday’s Best Wall Street Analyst Research Calls: Accenture, Caesars Entertainment, Datadog, Dupont, Epam Systems, Ferrari, Paychex, Rocket Lab, TeraWulf, and More
Pre-Market Stock Futures: Futures are exploding higher on news of a peace deal with Iran expected to be signed this Friday. This follows a historic Friday that saw the coming-out party of Space Exploration Technologies (NASDAQ: SPCX), widely known as Elon Musk’s SpaceX. The record-breaking size of the offering, raising $75 billion, the company’s debut ... Here Are Monday’s Best Wall Street Analyst Research Calls: Accenture, Caesars Entertainment, Datadog, Dupont, Epam Systems, Ferrari, Paychex, Rocket Lab, TeraWulf, and More
Here Are Monday’s Best Wall Street Analyst Research Calls: Accenture, Caesars Entertainment, Datadog, Dupont, Epam Systems, Ferrari, Paychex, Rocket Lab, TeraWulf, and More
Pre-Market Stock Futures: Futures are exploding higher on news of a peace deal with Iran expected to be signed this Friday. This follows a historic Friday that saw the coming-out party of Space Exploration Technologies (NASDAQ: SPCX), widely known as Elon Musk’s SpaceX. The record-breaking size of the offering, raising $75 billion, the company’s debut ... Here Are Monday’s Best Wall Street Analyst Research Calls: Accenture, Caesars Entertainment, Datadog, Dupont, Epam Systems, Ferrari, Paychex,
Analyst recommendations: Accenture, Caesars Entertainment, Roku, Adobe, Salesforce…
Every morning, find a selection of analysts' recommendations covering North America. The list only includes companies that have been the subject of a change of opinion or price target, or of a new...
Reasons for Commanders to hope and mope in 2026
One NFL analyst shares a reason for the Commanders to hope and mope in 2026.
NFL Analyst Makes Prediction for Bucs' Season
Former Super Bowl champion Logan Ryan envisions a dominant NFC South run for Tampa Bay, forecasting a double-digit win season fueled by Todd Bowles’ sophisticated defensive schemes.
Teladoc Health (TDOC) Stock Valuation As Analyst Sentiment Improves Despite Expected Earnings Decline
Analyst sentiment shift and near term expectations Teladoc Health (TDOC) is back on investors’ radar after analysts turned more positive in their earnings estimates, even as they still expect a 26.32% year over year decline in the upcoming report. This change in sentiment, paired with a recent 1.44% gain that outperformed key indices, has focused attention on how the company’s virtual care and mental health businesses might shape near term performance. See our latest analysis for Teladoc...
Why Accel Entertainment (ACEL) Is Up 9.5% After Beating Revenue Forecasts With 8.5% Growth
Earlier this quarter, Accel Entertainment reported quarterly revenue growth of 8.5% year on year, surpassing analyst expectations even as operating income trends were mixed. This revenue surprise stands out because it reflects resilience in Accel’s local gaming footprint while many consumer discretionary peers also beat sales forecasts. Next, we’ll examine how this stronger-than-expected revenue performance may influence Accel Entertainment’s existing investment narrative and growth...
"I Don't Do Anything I Don't Enjoy" - The Business Philosophy That Made Terry Bradshaw a Winner Off the Field
Terry Bradshaw, Hall of Fame Quarterback, 4-Time Super Bowl champion with the Pittsburgh Steelers, Emmy-Award winning studio analyst with the NFL on Fox and Founder of Bradshaw Bourbon and Bradshaw Quarter horses joins Sports Business Radio for a wide-ranging conversation. Bradshaw discusses his Hall of Fame career with the Steelers (where he went 4-0 in the Super Bowl). Bradshaw returned to Pittsburgh earlier this year for the NFL Draft and he shares his feelings about his relationship now with
One analyst bullish on highly-criticized 49ers draft pick
The 49ers RB2 battle is going to heat up this summer in San Francisco.
Gregg Jarrett: Banking discrimination based on politics is illegal
Fox News legal analyst Gregg Jarrett explains that banking discrimination based on political or religious beliefs violates federal and state laws.
What Do Analysts Think About Universal Health Services (UHS) Amid Its Decline To 52-Week Low?
Universal Health Services, Inc. (NYSE:UHS), with a forward P/E of 6.17x and upside potential of 48.10%, is among the top 10 lowest forward P/E stocks in the S&P 500. Universal Health Services, Inc. (NYSE:UHS) has been under sustained pressure, but analysts see the selloff as increasingly disconnected from the company’s underlying setup. Universal Health Services, […]
Assessing Accel Entertainment (ACEL) Valuation After A Mixed Q1 Earnings Beat And Modest Share Price Reaction
Q1 report and tempered market reaction Accel Entertainment (ACEL) recently posted its Q1 results, with revenue up 8.5% year over year and ahead of analyst expectations, while earnings per share also beat forecasts but adjusted operating income fell short. The stock has seen a modest move higher since the release, suggesting that investors are weighing stronger top line and EPS figures against the softer adjusted operating income performance as they reassess the company’s current setup. See...
The Supply Side: Walmart continues to expand its beauty business
The sale of beauty products is already a huge business at Walmart, with the retailer garnering roughly 20% of the estimated $107 billion industry sales annually, according to analysts at...
Trump labels Stephen A. Smith as ‘arrogant fool’ after criticism
President Trump on Wednesday slammed sports commentator Stephen A. Smith amid their feud, calling the ESPN analyst an “arrogant fool.” “Stephen A. Smith is an arrogant fool, a low IQ individual,” T…
Apple’s iOS 27 goes all agentic on compromised passwords
iBiz might not win the AI race, but analysts say it's focusing on features people may actually use
Truist says Meta has found its next $20 billion business, stock set to gain more than 40%
Analysts at Truist estimate Meta's new subscription model could generate over $20 billion in revenue by 2030.
We can create the future of science right now
Paul Litvak is the founder and Executive Director of the Robyn Dawes Institute and a Visiting Scholar at UC Berkeley. He has a PhD in Behavioral Decision Research from Carnegie Mellon where he studied emotions and the sunk cost bias. Over 15 years in industry, he solved a wide range of challenging technical problems. At Meta he created models optimizing the ad review process. At Google he ran experiments to measure social influence. At Airbnb, he was a product manager leading machine learning teams optimizing search ranking and price suggestions. He also co-founded and led product at Rhythmic Health, a venture-backed biosensing startup, creating an accurate low cost system using a color changing strip and a smart phone to measure salivary lactate. The bottleneck At this point, it is uncontroversial to say that science needs to stop using the PDF article as the unit of knowledge and currency. The unbearable slowness of scientific publishing, the profit motive and margins: I’m not saying anything new. The PDF also sucks because it’s hard to extract structured information, which makes it hard to do evidence synthesis. As a result, we do much less evidence synthesis than is needed. And evidence synthesis ultimately undergirds most policy and medical decision-making. I can see second-by-second real-time odds for any sporting or newsworthy event, but a school board can’t see the best evidence on whether their 8th graders should be taught algebra. As a society, we don’t treat this as an important problem. Again, not controversial. Not only is the problem well understood, but the solution has already been laid out. What we need is AI-assisted living evidence synthesis - (1) an open knowledge graph of atomic claims, (2) claims linked to evidence, (3) assessment and synthesis of each piece of evidence, and (4) continuous updating with new data. What few realize (yet) is that the technical capacity to build this vision for a significant portion of science already exists. Not only that, scientists and startup teams are already building many of these components. I know this because I’ve been surveying the space and talking to many of the builders. There are some missing pieces: for example, evaluations of how well some of the components work. But at this point, most of what’s missing is a fully end-to-end working integration of all of these parts. In the rest of this essay, I’m going to lay out all the parts of a working living evidence layer for science and who is working on them, and propose concrete next steps for building this system. What’s now possible The diagram above outlines the components of a living evidence synthesis platform, including some of the teams working on each component1. Scientific PDFs are processed into claims with associated evidence. The evidence is subjected to a forensic audit, methodological evaluation and robustness and reproducibility checks. Finally it’s given a weight in a continuously updating synthesis. What follows is a description and status of each component and a few of the teams working on them. Document understanding The first thing you need to be able to do is turn an article into structured data. Mostly that means parsing PDFs. There are often multicolumn layouts that confuse non-specialized PDF to text processing libraries. For scientific papers, there is the added complexity of parsing formulas and tables and figures. This is a really hot area - there are startups offering APIs, and it seems like a new open source package gets posted to Github every few weeks. What follows isn’t exhaustive. A package called GROBID was the state of the art for a while, they didn’t update their package for nearly two years until very recently. In the meantime reducto.ai released an AI powered PDF extraction API, PaddleOCR became popular, IBM released a model called Docling, and both Mistral and Gemini created models and libraries. I also know of at least one other well-funded psychology research group working on a paper parser. By contrast, there are few open evals in this space, with no extensive evals for complex table comprehension in particular. Nonetheless, I’m confident this will be a solved problem soon, given the combination of LLM advances and developer interest. Hypothesis level extraction There has been increasing interest in comprehending the extracted text of papers and linking information to evidence for each hypothesis. A lot of work has already been done. Trialstreamer (Marshall et al. 2020) and RobotReviewer LIVE (Marshall et al. 2023) demonstrated automated extraction of trial population, intervention, and outcome at scale on clinical RCTs. PaperQA2 (Skarlinski et al. 2024) and Ai2 ScholarQA (2024) extended this to retrieval-augmented question answering with citation grounding. Elicit, Consensus, and SciSpace operationalized claim-level extraction for end users. OpenEval (Booeshaghi et al. 2026) is the most recent and most ambitious: 1.96 million atomic claims extracted from 16,087 eLife manuscripts using Claude Sonnet 4.5, grouped into ~299,000 results, with LLM evaluations showing 81% agreement with human peer review on a 2,487-paper subset. None of these solutions link claims to test-statistics, as you would need to evaluate randomized controlled trials. This is why I built the evidence.guide API - to extract hypotheses and associated test statistics from behavioral science papers. The best public eval of this kind of extraction I’m aware of comes from the recent SCORE project - they had humans code thousands of psychology papers to extract their claims by hand. It would be extremely helpful to the world if all scientific PDFs were available as structured open data. I’ve been working to make this happen, both directly at Berkeley and through coordination with large entities I can’t yet speak of; as hard as it is to do, I think it’s possible2. Forensic audit A lot of work has been done on forensic audit, but some gaps remain. Of course, for biology papers that rely on images for evidence, there are a variety of tools (notably Proofig and ImageTwin) to spot anomalies. These are still well short of what sleuths like Elizabeth Bik can do on her own, but these tools are constant companions among fraud analysts. There’s someone working on auditing Excel files for anomalies, and a number of teams are automating numerical checks like GRIM and SPRITE, including Scrutiny project, the INSPECT-SR team as well as statcheck. The regcheck team is building a way to use AI to compare preregistrations to analyses in papers, to ensure there aren’t significant deviations. Nonetheless, there are many other kinds of anomalies to screen for, both public and less publicly known. And there are no formal evals for anomaly detection that I’m aware of. Still, there’s a lot to draw from in this space and I’m pretty certain we will be able to scan papers for most kinds of obvious anomalies in the near future. Methodological review This area has been white hot, though I fear for many of the startups in this space, because this capability may become commoditized. There are at least six different AI peer review companies, including Refine.ink, Reviewer3, ReviewerZero.ai, Q.E.D. Science, Paper Wizard, and Isitcredible. Coarse (a pun on refine) was also recently created as an open source alternative. These systems provide qualitative feedback on the content of papers, spotting methodological weaknesses and mathematical errors. They seem to work pretty well, and many academics report bitterly that they exceed the average quality of typical peer reviewers. But there are few evals here either. What evals exist so far involve using LLM-as-judge (circularity problems abound) or comparing against human reviews of questionable quality. What you’d ideally want is an eval that measures capturing known errors in papers3. Reproducibility and robustness Another active area has been using AI agents to automate computational reproducibility4 and robustness5 checks in papers that report numerical results. For more recent papers where data and code are available, AI agents can see whether they can re-run the analyses and produce the numbers reported in the published paper. In addition to a handful of individual academics who have been experimenting using Claude Code for this, the Institute for Replication is a leading group working on building an end to end system. The evals related to this problem are the most mature, with CORE-Bench (Siegel, Kapoor, Narayanan 2024) and PaperBench (OpenAI 2025) available to benchmark agents on this task. There is also work on getting AI agents to test alternative ways of analyzing the data to ensure the results are robust to small analytic design choices. Synthesis This is the most underdeveloped area where significant investment is required. Although some automated evidence synthesis systems exist — for example, otto-sr is building an AI agent to write systematic reviews — none of these incorporate the full range of paper level signals to weight evidence appropriately. Nor is there anything like an eval or a gold standard for a good systematic review. Arguably Cochrane reviews are the closest we have to gold standard human systematic reviews, though I’ve heard academics in the know complain about their uneven quality. A key question for a synthesis platform is how to weight anomalies and methodological issues in assessing the quality of a piece of evidence. This is an unsolved problem and one I’m very keen to work on. Continuous updating There are many pieces of basic infrastructure available for monitoring for new research and initiating updates. OpenAlex is the current open citation graph. Retraction Watch integrated into Crossref in October 2023. Scite tracks how citations support, contrast, or mention prior claims. The Living Evidence Network demonstrated continuous-update workflows in clinical guidelines. Engineering this is a relatively straightforward task. When you look over this technical architecture and all the progress being made, it’s hard not to be optimistic that a living guide to scientific evidence will be built. The stakeholders are ready The social infrastructure for this is starting to coalesce — it’s not just a pie in the sky academic exercise to imagine this coming into existence. Institutions like the Center for Open Science, the Institute for Replication, the INSPECT-SR, the Living Evidence Network and more are all working on scaling work to improve research quality. Funders are also aligned. The Sloan Foundation has funded living evidence work through COS. Coefficient Giving supports the Institute for Replication and COS. The Astera Institute and the Institute for Progress have shown interest in this space. NIH has established an Office for Replication and Reproducibility. Although there are (very unfortunately) serious headwinds in science funding generally, there is an active group of funders interested in metascience. A brief word about what I’ve been doing at RDI. First, as a Visiting Scholar at Berkeley I’ve been actively figuring out how a non-profit and a public university can conduct and make public the results of large-scale academic article data mining. With some of the money I raised from donors, I commissioned a legal analysis of recent case law and publisher text data mining (TDM) agreements in order to understand whether a massive open data mining of academic articles is possible (with caveats, it is). I’ve also been working to bring together stakeholders in this space, and identify gaps. I’ve also been doing some software development in this space, with more to come. A pilot proposal The assumption undergirding all of this is that an AI, given all this information, would make the right judgment about a scientific claim with lots of conflicting evidence, weighing all the factors appropriately. That’s the hypothesis we need to test. Randomized control trial research is the best place to focus on first. RCTs are used to make many of the important decisions in society - from medical trials to public policy changes. And they use a relatively uniform set of inferential statistics with lots of known and available diagnostics. Behavioral science experiments, within the broader realm of RCTs, should be first used as a testbed whose results can be generalized. Because behavioral science is at the vanguard of open science practices, replications abound (there are thousands of them) to serve as ground truth training data. Key Hypothesis Therefore the pilot would test, in behavioral RCTs that have been replicated, whether the quality of evidence for a claim can be used to accurately predict whether that claim will replicate. Secondary Hypotheses Compared to claims that replicated, non-replicated claims demonstrate a greater share of forensic anomalies in their source literatures. Hypothesis level claim and statistic extraction is accurate enough to scale living evidence without onerous human review costs. Replication prediction is more accurate than prediction markets6 or journal prestige. If all the different quality signals we gather do accurately predict which studies will replicate, then we can use that model to score evidence to power the living evidence layer. Why this is informative regardless of outcome If the pilot succeeds, the architecture extends to medical RCTs (where Living Evidence already operates and integration is mostly about claim representation), then to slices of basic biology with stable replication structure. If it fails, the field learns which quality signals are load-bearing and which ones metascience has oversold. Either result is a contribution to knowing what the literature supports. Implications for funders Because this burgeoning ecosystem of builders already exists, a well-informed philanthropic or government funder could play a crucial catalyzing role in bringing this future about. They could play at least three roles: creating open structured datasets, publishing open benchmarks and incentivizing the solving of key technical challenges. First, open archives of papers that the government maintains, like PubMed, could be turned into structured data amenable to large scale metascience and claim aggregation. I know the US government already has an interest in doing this, though some key open questions remain unanswered. How do you determine the best models and systems for accurately extracting information from papers? How can you establish a robust way to allow researchers to flag errors and correct them? And finally, how do you create a legal regime in working with publishers to maximize the scope of available papers? For the latter, a university or a private philanthropy may be better positioned to make structured data publicly available under journal subscription terms or fair use. Philanthropists or government funders could also coordinate to create or commission benchmarks that evaluate whether important problems have been solved. For example, an open benchmark for claim extraction from a range of different scientific article types would be extremely helpful. Ensuring the underlying data are accurate is vital for creating these evaluations. I’ve discussed opportunistically using various human-created datasets for this purpose, but a consistent problem is that errors in human data make it difficult for them to serve as a gold standard. Finally, with structured data and benchmarks available, the government or private philanthropy could use them to incentivize groups to develop machine learning systems that meet these benchmarks. Prizes are one potentially valuable tool for this. For example, you could establish a prize for a system that accurately updates a living meta-analysis for a small set of claims. Prizes are particularly useful as signals of problem importance, and can help create vibrant ecosystems of public and private research—see, for example the role the government played in kickstarting the current work on nuclear fusion. Conclusion The drawbacks of the current scientific publishing system are known. Scientists agree, metascientists agree, philanthropists agree: the published PDF plus citation graph isn’t the right substrate for maintaining a representation of the evidence base in science. The pieces needed to build the alternative either already exist or are rapidly taking shape. The community is forming around exactly this problem, with concrete partnerships and shared infrastructure. A pilot should start on behavioral science RCTs because that’s the slice of empirical science most amenable to legibility, where replication ground truth is richest, and where the failure modes are best documented. What’s been missing is the galvanizing mission to assemble these pieces into something that works. That’s what I’m proposing to build. *** 1 I have a broader field map that I’ll release publicly soon. This is me, building in public! 2 If this is something that you are excited about, please reach out and talk to me. 3 More on this very soon too! 4 This tests whether, given the code and the data, you can get the same statistics as reported in the published paper. 5 This tests whether the results are the same as a paper’s given alternative analytical decisions in conducting the analysis (like outlier omission). Closely related is the idea of a “multiverse” where you come up with many different ways of answering the same underlying research question with the same data, and test whether the results hold in all those alternative methods. There’s been work on the latter as well. 6 Some of the replications, e.g. those from the SCORE project, had paired the experiments with forecasts from prediction markets. So we get to look at this for free.
US consumers are rethinking their spending, retailers say
U.S. consumers haven’t stopped spending money since the Iran war drove up fuel prices, but many shoppers are reassessing what they buy and where, according to company executives and retail analysts. The behavior changes observed so far are subtle, such as altered routines for buying gasoline and fewer visits to clothing and furniture stores. They […]
The Odds: Trump’s hometown
CNN News Central’s John Berman and Chief Data Analyst Harry Enten explore what the latest polling and prediction markets say about the President’s popularity in his hometown of New York City.
Resuming War Is a Short-Term Political Boon for Netanyahu, but Grim Choices Await
If President Trump forces Israel to stand down against Iran, analysts say, it could leave Israel hindered from responding forcefully to attacks by Hezbollah.
Political data analyst weighs in after Trump slams California ballot count
ESPN analyst says former Falcons RB is 'interesting trade candidate'
Former Falcons RB Tyler Allgeier could be trade target in Cardinals' crowded backfield
How The Investment Story For Primary Health Properties (LSE:PHP) Is Evolving Without A New Price Target
Primary Health Properties has seen no change in its current price target, providing investors with a steady reference point for how analysts are framing the stock. As the story around the company develops, you will see how to track fresh data and sentiment so you can keep up with the evolving analyst narrative over time. Stay updated as the Fair Value for Primary Health Properties shifts by adding it to your watchlist or portfolio. Alternatively, explore our Community to discover new...
Evaluating Expand Energy (EXE) After Business Shift And Barclays Downgrade
Analyst downgrade meets business reset at Expand Energy Expand Energy (EXE) is back in focus after the company outlined a new emphasis on gas marketing and commercial optimization, while Barclays downgraded the stock, highlighting a weaker gas outlook and fewer clear near term catalysts. See our latest analysis for Expand Energy. At a share price of $92.07, the stock has fallen about 15% to 20% on a 3 month and 1 year share price basis, while 3 and 5 year total shareholder returns remain...
Gil M Soffer
Scope of work: A former federal prosecutor, Soffer became chairman of Katten in 2024, leading 1,500 attorneys and professionals. Previously, he was Chicago managing partner and co-chaired the firm’s litigation practice.Significant case: He serves as a five-year independent monitor in a global opioid settlement and was previously a DOJ/SEC-appointed corporate compliance monitor in a major Foreign Corrupt Practices Act case.Other contributions: Soffer is on the U.S. District Court for the Northern District of Illinois' Racial Justice Diversity Committee, is WLS-TV/Channel 7's chief legal analyst and headed the Chicago Bar Foundation Investing in Justice Campaign that raised $1.4 million for pro bono services.
Kansas City Chiefs: ESPN Expert Drops Major Patrick Mahomes Prediction
Patrick Mahomes and the Kansas City Chiefs are once again entering a season with championship expectations, but one prediction has elevated the conversation surrounding the star quarterback even further. An NFL analyst recently projected that Mahomes will capture the third Most Valuable Player award of his career during the 2026 season, a forecast that underscores […] The post Kansas City Chiefs: ESPN Expert Drops Major Patrick Mahomes Prediction appeared first on Gridiron Heroics.
How The Story Is Shifting For Phibro Animal Health (PAHC) As Analysts Reset Fair Value
The latest analyst update trims Phibro Animal Health’s assessed fair value from US$48.50 to US$45.60, bringing it closer to a cluster of price targets around US$44 to US$45.60. This shift aligns with more cautious commentary around regulatory risks and how the stock compares with peers. Read on to see what this may mean for you and how to keep track of the evolving analyst story around Phibro Animal Health. Wall Street's queuing for one rocket. While SpaceX counts down to its IPO, other...
Why Oscar Health (OSCR) Is Up 10.3% After Leadership Shift And Analyst Upgrade
Oscar Health, Inc. recently amended and restated its employment agreement with co-founder Mario Schlosser as he moved from President of Technology and Chief Technology Officer to Co-Founder & Advisor to the CEO, effective June 1, 2026, while he continues to support the company’s artificial intelligence and digital health agenda and remains on the Board. At the same time, a major Wall Street firm upgraded its view on Oscar Health after Q1 2026 results exceeded expectations and reinforced...
How The Mixed Analyst Calls Are Reframing The Cardinal Health (CAH) Investment Story
Cardinal Health is back in focus as fresh Street research reshapes the price target conversation, with several firms trimming their targets while one raises its view and another starts coverage on a bullish footing. Those mixed calls reflect a split between analysts who see room for upside if execution holds and others who are more cautious about how much to pay for the stock right now. As you read on, you will see how to track these shifting views and what they might mean for your own...
Colts’ Daniel Jones Given Concerning 2026 Projection
Daniel Jones has his share of doubters, and one NFL analyst is seemingly betting against him succeeding next season.
Bills, Vikings Connected in Massive $140M Trade Rumor
A proposal has been made from one prominent NFL Analyst, who predicted a blockbuster Justin Jefferson trade rumor connecting the Bills, Vikings.
CFB analyst provides intriguing prediction for Texas A&M's 2026 season
Popular X account CFB Home predicts Texas A&M to finish 10-2 in 2026, with both losses coming at the end of the year.
ESPN bolsters WNBA coverage, adds rules analyst for broadcasts
The WNBA’s new collective bargaining agreement, which cemented the league’s meteoric rise, was made possible thanks to the league’s new $2.2 billion media rights deal running through 2036. As part of the deal, ESPN and ABC will air five of the next 11 WNBA Finals and a conference finals series in eight of the 11…
NFL analyst makes bold prediction for Chargers' Tre Harris
Chargers wide receiver Tre' Harris could play a big role in 2026. An NFL analyst certainly believes he will.
UnitedHealth Stock Rises. Why the Health Insurer Is Leading the Dow to Sharp Gains.
Shares of UnitedHealth Group receive votes of confidence from analysts at BofA Securities and Morgan Stanley.
Kuo: Apple's Vision Pro Successors Off the Table as Focus Shifts to Smart Glasses
Incoming Apple CEO John Ternus signed off on a major revision of Apple's Vision Pro and smart glasses plans, consolidating Apple's work in the category. According to Apple analyst Ming-Chi Kuo, Ternus nixed plans for a second Vision Pro and a lighter Vision Air. Kuo says there are only two smart glasses products in development, including the AI smart glasses that Apple is creating to rival the Meta Ray-Bans and a display-equipped set of AR smart glasses.
MacBook Neo is So Popular That Apple Reportedly Doubled Production
On an earnings call in late April, Apple's CEO Tim Cook said that customer response to the MacBook Neo was "off the charts," and the popularity of the laptop has reportedly led the company to significantly boost production. Apple supply chain analyst Ming-Chi Kuo this week said he believes that MacBook Neo shipments to Apple were doubled from an initial target of 5 million units to 10 million units in 2026 at some point after the laptop launched in March.
Macy's Lifts Sales Outlook; GameStop Collectibles Business
On this episode of Stock Movers with John Tucker: - Macy's (M) shares are on the move after it lifted its sales outlook for the year, a sign that the company's focus on growing its luxury business and improving its assortment is paying off. - GameStop (GME) shares are climbing after the video-game retailer reported a record quarterly profit driven by its collectibles business. Sales overall climbed 14% to $835.3 million. Net income of $389.6 million was the highest ever for a quarter in the company's history, GameStop said in a regulatory filing Tuesday. - Palo Alto (PANW) shares are dropping as the security software company reported results following a 61% year-to-date rally. The company reported third-quarter results that beat the average analyst expectation and raised its full-year forecast for key metrics, but failed to meet elevated buyside expectations.